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Abstract
Background: While numerous studies have explored the patient experience of dialysis or other end-stage kidney disease
(ESKD) treatments, few have explored the process of transitioning between dialysis modalities. This study aimed to
develop an in-depth understanding of patient and caregiver perceptions and experiences of the transition from peritoneal
to haemodialysis (HD) and to identify ways in which transitions can be optimised.
Methods: Fifty-four in-depth, semi-structured interviews were undertaken at six study sites across the West Midlands,
UK (n ¼ 23), and Queensland, Australia (n ¼ 31). Thirty-nine participants were patients with ESKD; the remainder were
family members. An inductive analytical approach was employed, with findings synthesised across sites to identify themes
that transcended country differences.
Results: Of the 39 patient transitions, only 4 patients reported a wholly negative transition experience. Three cross-
cutting themes identified common transition experiences and areas perceived to make a difference to the treatment
transition: resistance to change and fear of HD; transition experience shared with family; and bodily adjustment and sense
of self.
Conclusion: Although each transition is unique to the individual and their circumstances, kidney care services could
optimise the process by recognising these patient-led themes and developing strategies that engage with them. Kidney
care services should consider ways to keep patients aware of potential future treatment options and present them
objectively. There is potential value in integrating expert support before and during treatment transitions to identify and
address patient and family concerns.
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Introduction
Patients with end-stage kidney disease (ESKD) may be
treated using home therapies (home haemodialysis (HD)
or peritoneal dialysis (PD)), incentre HD, transplantation
or conservative care. Many patients with ESKD progress
through a series of kidney replacement therapies due to
changing clinical needs, treatment complications or patient
preferences.1,2 The change from PD to other modalities is
particularly common,3 with a third of patients moving to
another form of dialysis (usually HD) within their first
3 years on PD.4–6 Transitions from PD may be charac-
terised broadly as planned, where PD effectiveness declines
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over time until it is no longer viable, or unplanned, where –
usually due to infection or peritoneal membrane failure –
patients without a stable fistula require emergency transfer
to HD.7,8 Changing dialysis modality requires physical and
psychological adaptations which may be associated with
substantial distress,9,10 and disruption to lifestyles and rela-
tionships.11 Evidence suggests the transitional period
(weeks before to months afterwards) may also entail heigh-
tened morbidity and mortality risk compared with other
points in the ESKD pathway.12 While numerous studies
have explored the patient experience of dialysis or other
ESKD treatments,13 few have explored the process of tran-
sitioning between dialysis modalities. Understanding
patient and caregiver perspectives about treatment transi-
tions is essential towards ensuring such transitions are
effective and patient care is optimised.4,14,15
This study is part of the INTEGRATED consortium12
and aimed to develop in-depth understandings of patient
and caregiver experiences of transitions from PD to HD,
barriers and facilitators to successful transitions and views
about how clinical practice could improve.
Methods
The published protocol summarises the methods.12 Briefly,
in-depth, semi-structured interviews were undertaken at
three study sites in the West Midlands, UK, and three in
Queensland, Australia. Incorporating perspectives across
two continents allowed identification of treatment transi-
tion experiences likely to have relevance across different
national contexts. Ethical approval was obtained from the
Health Research Authority (Ref: 237901) and London
Bridge Research Ethics Committee on 31 May 2018 (Ref:
18/LO/0974). Research Governance approval (Ref:
RG_17-252) was obtained from each participating study
site in England and Australia.
Participants and recruitment
Eligible patients were identified by clinical staff and were
aged 18 and over, had transitioned from PD to incentre HD
for at least 30 consecutive days between 2 and 18 months
previously, and were clinically stable. Convenience sam-
pling was used, with potential participants approached
sequentially as they became eligible. Study packs contain-
ing an invitation letter, Participant Information Sheet and
consent form were posted to eligible patients 7–14 days
before their next outpatient appointment. Those who
wished to participate gave permission for their details to
be passed to the research team who then arranged an inter-
view. Where possible, adult caregivers (all of whom self-
identified as ‘family members’ – spouses, parents or
children) providing support to a transitioning patient were
also recruited, either at the patient’s clinic appointment if
accompanying them or via a carer pack given to the patient.
One participant identified did not speak English. This
participant was approached and interviewed through a
translation service.
Data collection
Interviews were conducted face-to-face at a participant’s
home or their dialysis unit, or via telephone. Detailed inter-
view topic guides for patients and caregivers are included as
supplementary material. Patients and family members were
interviewed separately if possible, although four interviews
were undertaken jointly. The interview topic guide sought to
understand participants’ experience of the transition from
PD to HD, including what they knew about the change, why
it was happening and the discussions they had before and
after the transition and with whom. Interviews focused on
patients’ most recent transition, but those who had experi-
enced previous transitions were encouraged to reflect on
how those experiences were similar to or different from their
most recent transition. All interviews were audio-recorded
(range 15–60 min) and independently transcribed verbatim,
and transcripts were proofread against original recordings to
ensure accuracy. The same researchers (KA and KS) under-
took the England and Australia interviews. All participants
provided written informed consent.
Analysis
An inductive analytical approach was employed, without a
predetermined coding framework or a priori expectations
about study findings.16 Two researchers (KA and KS) inde-
pendently analysed 10–15% of the transcripts to create an
initial coding framework, using thematic analysis.17 Data that
did not fit existing codes or themes were discussed by the
research team and amendments made or new codes added
until all data had been analysed. Analysis was initially under-
taken separately for England and Australia by two researchers
(KA and KS). Themes were then compared across the two
nations and discussed in the research team in order to identify
themes that transcended country differences.
Results
Fifty-four individuals participated in total (23 in England
and 31 in Australia). Fifteen were family members; the
remaining 39 were patients with ESKD (Table 1). Clinical
information such as the cause of patients’ kidney disease,
comorbidities or diabetic status was not available unless
patients described this during their interview.
Transition type
Four discrete transition types were identified: (i) planned
transition with long lead-in time, allowing opportunity for
patient–healthcare professional (HCP) discussion (n ¼ 7);
(ii) ‘hybrid transition’ where the transfer between therapies
was planned, but the point of transition itself was
unplanned/emergency (n ¼ 8); (iii) patient-led transition
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which could have been planned or unplanned but where the
patient requested the treatment change (n ¼ 7), and (iv)
unplanned/emergency transition to HD, usually due to peri-
tonitis (n¼ 17). Despite the different transition experiences
observed, of the 39 ‘patient journeys’ assessed, most parti-
cipants (n ¼ 35) described their transition as positive,
and only 4 patients reported a wholly negative experience.
A number of patients with broadly positive transitions
also described some negative elements to their treatment
change.
Interview themes
Interview data illustrate that each experience of transition is
unique to each patient’s individual situation. Despite this,
three themes identified common transition experiences and
areas that interviewees believed affected the treatment tran-
sition (Table 2). Themes were generated inductively, prior-
itising the most relevant findings evidenced in both
national contexts and across transition types.
Resistance to change and fear of HD. For most patients,
accepting HD was a gradual process. Patients initially
anticipated losses of freedom with a move to HD, yet these
losses were not borne out for most in practice.
Anticipatory losses. Many patients initially associated HD
with negative impacts on their lives, affecting control over
treatment (self-care), ability to work, maintaining current
lifestyle and entailing an unwanted move away from the
privacy of their home environment.
Because it’s three days, and they told me this, three days at the
hospital every week you know and that’s why and I didn’t
want hospital at all, not at all . . . . (Site 2, patient)
. . . my main concern throughout all of this process is still to
be able to go to work and like bring money in. (Site 4, patient)
A few patients revealed their fear and negative antici-
pation of HD were so strong they would have preferred
death to the treatment change.
I feel well in myself and that but when I first come down here I
wished I was dead. I’d had it. Fair enough . . . I just wished I
wasn’t here. I was . . . didn’t want to do nothing, I couldn’t do
nothing, just felt “Why live like this?” (Site 6, patient)
Gains in retrospect. Many patients found HD less challen-
ging than anticipated. Some expressed surprise about this,
Table 1. Characteristics of study participants.
Characteristic Patients Family membersa
England
Gender (n) (%)
Male 11 (64.7) 1 (16.7)














Country total 17 6
Australia
Gender (n) (%)
Male 13 (59.1) 3 (33.3)













Country total 22 9
Grand total 39 15
aAge group and ethnicity were not recorded for family members who
participated in the study.
b‘Other’ ethnic group in England ¼ Hispanic.
c‘Other’ ethnic group in Australia ¼ Hispanic (n ¼ 1); Indigenous Austra-
lian (n ¼ 1); Middle Eastern (n ¼ 1).
Table 2. Summary of themes and subthemes.
Themes Subthemes
Resistance to change and fear of HD Patients initially anticipate losses with transitions to HD
Patients experience gains in retrospect of transition
Psychological readiness
The experience of transition is shared with family Impact of PD on family ‘unit’ affects patient experience of transition
Carers’ relief at transition – multiple reasons
Bodily adjustment and sense of self Coping with bowel incontinence
Creating and using fistulas
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and even found the move to incentre HD more enabling and
less stressful than home treatment.
. . . the fear of having to go out to a unit and thinking I
wouldn’t be able to do things my way, but dialysis fits in
perfectly with my life the way it is, it’s better for me now than
it was when I was doing PD. (Site 1, patient)
Gains were perceived in particular where HD allowed
much more ‘treatment-free’ time:
It’s good (HD) because it gives me some freedom. I do 4 ½
hours three days a week, so that’s 13 hours a week therapy as
opposed to 70 or 84 hours a week (on PD). (Site 2, patient)
The switch to HD had made many patients more aware
of their unsuitability to PD. Some patients who had only
ever used PD noted difficulties in assessing how unwell
they had become prior to their transition, and these patients
saw some negative effects of PD in hindsight that they had
not been fully aware of before changing treatment.
. . . they (PD staff) seemed satisfied that you’re doing alright
when I just wasn’t you know . . . I remember going down by the
river for something to eat and there was this short bank to get
back onto like the main drag and I honestly thought I was
going to pass out at some stage I’d gone all dizzy and I grabbed
hold of [wife] I said I think I’m going to go here. (Site 2,
patient)
In a few cases, the gains made by transitioning to HD
made patients question why they had been offered PD. This
patient experienced a severe infection after starting PD:
I just don’t see the point in having PD, you have to go in to
surgery to get it done and then if you get infected you have get
surgery to get it taken out. You get constipated all the time.
There’s a lot of things that just don’t make it as good, whereas
haemo, I don’t think I’ve had a problem. (Site 5, patient)
People tended to describe periods where they struggled
in silence when their PD treatment was not performing and
feeling personally responsible for PD not working well:
At first I thought it was my fault with my fluid and when I went
on to haemo they went “no you can’t help it it’s because of
this, that and the other”. They helped me relax about it all and I
think with being so stressed and tense thinking it was me, that
wasn’t helping either. (Site 3, patient)
An important caveat to the ‘gains in retrospect’ theme is
that for a few patients the reality of HD did live up to their
worst expectations’. Data identified cases of distress which
patients related to excessive travel to and from treatment;
coping with incontinence, fistulas and cannulation; dislike
of the atmosphere of HD units; and lack of confidence in
HCP’s expertise.
Psychological readiness. Resistance to HD was often
linked to phobia of needles. Some patients recounted going
against recommendations to transition to HD and extending
the duration of their PD to try to avoid it:
He [consultant] suggested moving over to HD because he
didn’t think the dialysis that I was doing was efficient enough
for me, but because of my fear of needles I point blank refused.
I’d rather just carry on the way I’m going and increase my
hours of dialysis. (Site 3, patient)
Several patients voiced the need for greater emotional
support to help them confront and accept the deterioration
of their condition and a change of dialysis modality:
It was really a shock and psychologically, I reckon they
should start talking to you, prepare you for what they’re
going to show you, what they’re going to do to you. I don’t
know, I felt somebody not from this world, it was just terri-
ble. (Site 5, patient)
The experience of transition is shared with family. During tran-
sitions, the experiences of patients and close family mem-
bers were strongly interconnected. This partner describes
how watching her husband’s physical and emotional
decline when using PD and subsequent recovery after tran-
sition to HD affected her:
I notice there’s a big change in him, when he was doing peri-
toneal he was angry with everybody. But now that he’s doing
haemo that has slowly dissipated. That makes me happy
because that’s what I strive for, to see him accomplishing
things that he wants to do with his life. (Site 5, family member)
Impact of PD on the family ‘unit’ affects patient experience of
transition. Where family had felt uncomfortable with home
treatment, this mediated how patients felt about a move to
HD. One patient described the additional caring responsi-
bility his wife took on after he had a leg amputated, which
made PD stressful for her:
But when it comes to all the work that she had to do and me,
only on one leg she had to help do everything. For her it was
too much work and I didn’t feel good about it. (Site 4, patient)
The wife of this patient expressed the positive effect that
she associates with her husband’s transition to HD:
It [HD] gives me that space and the break and the times I need
to, you know, me and the [0:07:06] on my own. No, it’s been
good. He feels a lot better in himself, he looks a lot better in
himself too since the change. (Site 4, family member)
Carers’ relief at transition. Many family members were
relieved when dialysis moved incentre. For many families,
having PD at home medicalised their living environment
and they were glad to reclaim their personal space:
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Once that machine went the thought of it coming back it filled
me with dread. I used to do the order and stock take, having it
there every single time we pulled on the drive the boxes were
there so you’re reminded, every single day of what’s happen-
ing. (Site 2, family member)
Bodily adjustment and sense of self. Coping with bowel incon-
tinence and creating and using the fistula for HD were
frequently described as problematic, and patients described
a negative emotional impact on their sense of self, which in
some cases caused disengagement with their dialysis
treatment.
Coping with bowel incontinence. Patients described anxiety
and shame, and a lack of control in connection to bowel
incontinence, especially in public settings like the HD unit
or when travelling to these settings in ambulances with
others. Although for some patients this issue predated their
treatment change, the incidence of bowel incontinence as a
new symptom was particularly pertinent during transitions
due to changes in medication regimens and had a strong
impact for several participants on their perception of their
transition:
When the diarrhoea gets really bad, it’s just out of control
when it happens. Every time I’m nervous, and I’m thinking
oh please don’t let it happen . . . and it worries me so much
before I leave home. It’s not a nice thing if you’re putting
people off. So that’s why sometimes I don’t come [to HD],
because of that reason. (Site 5, patient)
At first, the treatment created havoc with my plumbing. I
had permanent diarrhoea which was . . . well occasionally I
was coming home soiled because just not able to stop it, just
not able to do anything about it. (Site 2, patient)
Creating and using fistulas. Patients who found the cre-
ation of fistulas the most traumatic often felt they had little
prior warning or education about the need and purpose of
the fistula. Some were shocked and experienced additional
anxiety because of this.
Well I actually had no idea what a fistula was. I thought I was
going to have toggles coming out of my arm. So I was a bit,
yeah, shocked. (Site 2, patient)
For some, fistula creation was more disruptive than
anticipated. In some cases, there were multiple operations
and long-lasting changes to sensation.
Oh my fistula. I had two operations for that, but then it
stopped the blood flow to my fingers and my fingers were
going really numb and white and everything. I think they’re
thinking of putting one in this [other] arm and trying again.
(Site 1, patient)
People who highlighted the fistula as particularly
unpleasant were often those who had experienced ‘blown’
fistulas, in which the fistula wall was broken during can-
nulation and blood pumped into the surrounding tissue,
resulting in painful swelling and bruising.
Like the changeover [to HD] was just the fistula didn’t work,
my arm went black from that from where it blew out. So yeah,
I went back on the PD. (Site 4, patient)
Discussion
To our knowledge, this study represents the second, multi-
site qualitative investigation of dialysis modality transi-
tions and the first to include the perspectives of family
members. The broad aim of the programme of research,
to which this study contributes, is to generate evidence that
can enhance consideration of integrated dialysis pathways.3
To this end, this study found successful PD to HD transi-
tions require an awareness that treatment change is
required, support for the change, sufficient knowledge of
what the change will entail and the willingness and capac-
ity to implement the change. This implies that patients
should be made aware when beginning PD, that a future
change may be required, what the alternatives are, and
potential underlying reasons for the transition.18 In partic-
ular, this research shows patients may anticipate losses of
freedom and comfort with a move to HD, even when their
overall experience of treatment transition was described as
positive. Transition experiences were complex, with antici-
patory losses often offset by perceived freedom from
responsibility for self-care when moving to incentre dialy-
sis. Recent work undertaken in Belgium as part of the
INTEGRATED consortium reported similar findings
regarding this ‘paradox of control’ by patients during tran-
sitions from PD to HD.19 Another commonality between
these two studies is the importance drawn to how previous
‘frames of reference’ can influence the transition experi-
ence.19 In this study, the initial ‘resistence to change’ was
often mentioned in relation to previous negative ideas
about HD, either gained through direct experience or
implied by being guided towards PD initially by HCPs.
Planned transitions and those where patients initiated
discussions about changing dialysis treatment were more
likely to be viewed positively than those where transitions
were unplanned. Expert support during the transition phase
may be valuable, either to facilitate timely decisions about
transition in planned cases or to help patients and families
cope psychologically in emergency transitions. Such sup-
port may focus on acceptance of deterioration in their con-
dition; identifying and working with patients with needle
phobias, and support for emotionally challenging aspects
such as fistula issues. Peer support could also be used to
help patients build realistic expectations of the physical and
emotional impact of their treatment transition and identify
important non-medical issues.
A recent systematic review of dialysis decision-making
found that HCPs often focus on biomedical issues and
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prolonging life.20 This study captured the anxiety experi-
enced by family carers and subsequent relief at the transi-
tion to incentre HD. In many cases, relief was strongly
influenced by negative impacts on patient health and
well-being caused by the progressive failure of PD which
were alleviated by the change to a more clinically effective
treatment. Yet impacts on patients’ sense of self were par-
ticularly pertinent, and regular discussions between HCPs
and patients/family members may help clinicians under-
stand the impact of transitioning between treatments on the
day-to-day experience of patients and family members. The
example of patient anxiety about bowel incontinence
around the time of transition is particularly important – if
this may drive disengagement with dialysis, it is fundamen-
tal that clinicians are aware of this symptom and its conse-
quences for patients so that information provision and
HCP-patient communications can address these issues
openly. Treatment modalities should also be discussed
against an assessment of patient and family member capac-
ity,21,22 and the decision to start incentre HD should incor-
porate shared decision-making that helps patients make
informed treatment decisions.23
Issues raised in this study around the burden of home
dialysis for patients and caregivers reflect recent review
findings.24 In particular, patients’ appreciation of gains in
retrospect of moving on to HD often displayed a relative
lack of confidence of how they were managing PD. The
potential for ‘burnout’ is also evident, especially in the
narratives of relief expressed by caregivers after their rela-
tives transitioned to HD. It is important to note that the
participants reporting their experience in this study were
not a representative sample of people using PD. Partici-
pants had all transitioned from PD to HD and as such they
had either experienced an acute medical emergency or
declining clinical outcomes and related symptoms when
using PD.
Limitations
Interviewing participants at one time point poses a limita-
tion, as it prevents consideration of the longer-term reflec-
tions of patients and caregivers. However, this strategy
allowed us to capture a greater number of individual experi-
ences overall, maximising the range of experience within
the sample. Recruiting patients who had transitioned from
PD to HD over the previous 2–18 months gave a relatively
small sampling frame and all patients who gave consent
were selected to participate. Thus, while the study captured
diversity in individual characteristics, it did not recruit a
specific cross-section of participants that could be stratified
by age, ethnicity or sex. Within both countries just one
region was used for sampling, this may impact on the trans-
ferability of findings to other settings. There are limits to
the transferability of these findings as all participants,
except for one, were English speaking and the study was
conducted in high-income countries where PD is practiced
by a minority of patients.
Practice implications
To improve treatment transitions, renal care providers
should consider ways to improve patient awareness of pos-
sible future treatment options and present them objectively
by tailoring information and communications accordingly.
Patients yet to begin dialysis should be given information
about the positive and negative aspects of different treat-
ments to facilitate informed choice about dialysis modality
and the knowledge that this may need to change as their
ESKD progresses. Patients already receiving PD who are
developing problems that might require treatment change
in the near future should be offered information about HD
and the different models of care that are available. This
might involve incentre self-care, incentre shared care, total
dependence incentre, home-based self-care such as HD at
home or a more intensive search for a kidney donor when
transplantation is a viable option. There is also potential
value in integrating greater expert support during the tran-
sitional period that identifies the concerns of patients and
their families.
Conclusions
Patient and carer experiences of transitions from PD to HD
are often marked by initial resistance to treatment change;
the way the transition experience is shared with family
members; and bodily adjustments to treatment transition
which can be traumatic. Although each transition is unique
to an individual’s own circumstances, renal care providers
could optimise the transition process by recognising and
developing strategies that engage with these patient-led
themes.
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